DR SUNIL CHOPRA BSc MBBS (UK) MRCP (UK)
|
||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Date of Birth: Age: Sex: Nationality: Email: Telephone: |
27th September 1965 45 years Male British sunil.chopra3@btinternet.com 0790 8493183 |
| Educational Qualifications: | M.B.B.S, University of London, 1990 |
|
Degree of Bachelor of Science [Immunology], University College London, 1986 |
| GMC Status: | Registered with the General Medical Council (GMC) UK. Full Registration number 3328774 |
| Memberships: | British Medical Association (BMA) Royal Society of Medicine (RMS) British Association of Dermatology (BAD) Medical Defence Union (MDU) |
| Prizes: | National Amulree Prize for the Care of the Aged, 1989 Primary Health Care Prize 1988 ICI Elective Award 1988 |
| Research: |
|
| Jan 2005 – To date Barts and The London and BHR Trusts |
Investigation and clinical trials of nano liposomal encapsulation of Bleomycin for the topical treatment of Basal cell carcinomas and keloids. Research conducted in collaboration with Professor S Brocchini and Professor Navsaria H. |
| BSc Project | “Role of Tumour Necrosis Factor in immunity to Malaria”. |
| Undergraduate | “Increased General Practitioner consultation rates amongst carers of the elderly.” Prize winning project- National Amulree Prize in care of the elderly. |
| Postgraduate August 94-30/09/96 |
“The Neurovascular pathophysiology of Raynaud’s phenomenon”. I have used the techniques of quantitative immunohistochemistry and also in-vivo pharmacology to study Raynaud’s phenomenon of different aetiologies. I acquired the necessary skills in immunohistochemistry at the Royal Free Postgraduate Medical School under Professor JM Polak for one year and then established them at UCL. I have also established new techniques in the laboratory and developed an objective test for Vibration White Finger. |
| Notable Achievements in Dermatology: | Clinical Director and Founder of the London Dermatology Centre, Wimpole Street, London WC1, founded 2004. Ten thousand patients seen every year by ten Consultant Dermatologists |
|
Director and founder of SPS Healthcare. This is a company that specializes in developing drugs for delivery in skin disease. The company owns one granted patent and owns one submitted patent. SPS Healthcare collaborates with the following scientists |
|
Professor Atholl Johnston; Professor of Pharmacology Bart’s and the London Medical School |
|
Professor Stephen Brocchini Professor of Pharmacology, London School of Pharmacy |
| Dermatology Teaching Experience: | Middlesex University, Course Director, Certificate of Dermatology. This is a course to train General Practitioners with a special interest in Dermatology |
|
Undergraduate student teaching at Bart’s and the London Medical School. |
|
Barking and Dagenham General Practitioner Skin Club – Bimonthly teaching |
|
University College Hospital Accident and Emergency, regular teaching of SHOs and registrars |
|
London Dermatology Centre continuing medical education for GPs – Bimonthly teaching |
Employment History:
Dermatology Present Appointments: 01/06/01 – Present
| Name and Address of Employer | Grade and Specialty |
| University College London Medical School Division of Medicine | Honorary Senior Lecturer |
| Barking Havering and Redbridge NHS Trust | Honorary Consultant in Dermatology |
| London Dermatology Centre, Wimpole Street, London WC1 | Clinical Director and Founder |
| SPS Healthcare, London | Director and Founder |
| Middlesex University | Course Director Postgraduate Certificate in Dermatology |
Dermatology Previous Appointments
| Name and Address of Employer | Dates of Employment, Grade and Specialty |
| Barking and Havering and Redbridge NHS Trust | 01/08/01 – 01/09/08 Consultant Dermatologist |
| Bart’s and The London Hospitals | 01/08/01 – 01/09/08 Honorary Consultant Dermatologist |
| The Royal London Hospitals NHS Trust and Homerton Hospital NHS Trust | 01/10/00-31/07/01 Senior Clinical Fellow (Post CCST) |
| Royal London Hospitals NHS | 18/10/99-30/09/00 Specialist Registrar in Dermatology |
| Ealing and Hammersmith Hospitals | 01/06/98-17/10/99 Specialist Registrar in Dermatology |
| Imperial College School of Medicine | 01/06/98-17/10/99 Honorary Research Registrar |
| UCL Hospitals NHS Trust | 01/10/96-30/05/98 Specialist Registrar in Dermatology |
| University College London Medical School | 01/08/94-30/09/96* Research Registrar and Honorary Clinical Registrar in Dermatology to PM Dowd |
| Middlesex Hospital. | 01/02/93- 30/09/93 Senior House Officer in Dermatology to Drs TWE Robinson, JJH Gilkes, GM Levene and PM Dowd |
| Chase Farm Hospital, Enfield | 01/12/91-31/07/92 Senior House Officer in Dermatology to Dr Almeyda |
*Further Details:
UCL Hospitals NHS Trust - 01/10/96-30/05/98 - Specialist Registrar in Dermatology
1994 thesis entitled "The neurovascular pathophysiology of Raynaud's phenomenon". This involved clinically assessing 27 vibration exposed workers; on site at a British shipyard; for vibration white finger. Each subject’s cutaneous digital vascular responses to injected neuropeptides were assessed using planimetry and laser Doppler flow measurements. All subjects underwent digital cutaneous biopsy and immunostaining for neurovascular peptides. All of the above procedures were carried out on 6 patients with acrocyanosis and perniosis, 6 patients with Raynaud’s phenomenon associated with systemic sclerosis and 6 patients with primary Raynaud’s phenomenon.
The post also involved lecturing medical students, chiropodists, general practitioners and postgraduate students studying for the MRCP part II. I was one of the examiners for the MBBS Jenner Living Dermatology prize and project examiner to the London Foot Hospital. The clinical responsibilities involved one specialist cold related disorders clinic and cover for sick leave for the consultants.
General Medicine Previous Appointments
| Name and Address of Employer | Dates of Employment, Grade and Specialty |
| Addenbrookes Hospital, Cambridge | 01/11/93-01/02/94 Registrar in Chest Medicine and Intensive Care to Dr T W Higgenbottam and Dr G Park |
| Papworth Hospital, Cambridge | 01/03/94-31/07/94 Registrar in Chest Medicine to Dr J M Schneerson |
| Middlesex Hospital | 01/02/93-01/08/93 Senior House Officer in Dermatology and General Medicine |
| Middlesex Hospital | 01/8/92-31/01/93 Senior House Officer in HIV and Genitourinary Medicine |
| Chase Farm and Highlands Hospital | 01/08/91-31/07/92 Senior House Officer Rotation in General Medicine |
| Royal Free Hospital | 01/02/91-31/07/91 Senior House Officer in Accident and Emergency and Intensive Care |
| University College Hospital | 01/11/90-31/01/91 House Physician to M.D.R Sarner and Professor S.G. Bown |
| Middlesex Hospital | 01/08/90-31/10/90 House Physician to A.M Cassoni and M Coulter |
| Ipswich General Hospital | 01/02/90-31/07/90 House Surgeon to I.H.K. Scott |
| Patents: | Patent Granted: Patent Number: GB2398495 “A drug delivery preparation comprising at least one anti-tumour drug and a topical carrier for the drug” S Chopra and K Lau. 22 Aug 2007 |
| Patent Submitted: Patent filed 2007. Under Review “A topical stable flexible liposomal drug delivery system encapsulating bleomycin” S Chopra. |
|
| ‘Dermatological problems’ S Chopra, M Knight, and F Vega Lopez Manson’s 22nd Edition ‘Textbook of Infectious Disease’ 2009 | |
| Br J Dermatol. 2008 Sep; 159(3): 628-32. ‘Treatment of rosacea with intense pulsed light: significant improvement and long-lasting results’. Papageorgiou P, Clayton W, Norwood S, Chopra S, Rustin M. | |
|
ET Anthony, S Kantaria, G Moir, S Davison, S Chopra. ‘The stability of liposomal bleomycin and its penetration in human skin. Submitted to British Journal of Dermatology’. A case report on 3 patients with verrucae using liposomal bleomycin. A case report of the use of topical liposomal Bleomycin to treat a nodular BCC. E. T. Anthony, S. Kantaria, G. C. Moir and S. Chopra. ‘The penetrative abilities of liposomal in explanted keloids’ Clin Exp Dermatol. 2009 Apr; 34 (3): 408-9 |
|
Kuttikat A, Saeed T, Chopra B, Chopra S, Chakravarty K. ‘Nasal Wegener's and skin sarcoid--a rare combination of two granulomatous diseases’. Clin Rheumatol. 2006 Nov; 25(6): 895-7. |
|
Berth-Jones J, Arkwright PD, Marasovic D, Savani N, Aldridge CR, Leech SN, Morgan C, Clark SM, Ogilvie S, Chopra S, Harper JI, Smith CH, Rook GA, Friedmann PS. ‘Killed Mycobacterium vaccae suspension in children with moderate-to-severe atopic dermatitis: a randomized, double-blind, placebo-controlled trial’. Clin Exp Allergy. 2006 Sep;36(9):1115-21 |
|
Anthony E, Syed M, Vaiude P, Chopra S, Davies K, Nduka C, Shibu M, Moir GC. ‘A 6 year review of the clinical relevance of steroid therapy in keloid management’. International Proceedings of the 7th European Trauma Congress. May 2006. |
|
Kuttikat A, Saeed T, Chopra B, Chopra S, Chakravarty K. Nasal Wegener's and skin sarcoid-a rare combination of two granulomatous diseases. Clin Rheumatol 2005:1-3 |
|
Lau KG, Hattori Y, Chopra S, O'Toole EA, Storey A, Nagai T, et al. ‘Ultra-deformable liposomes containing bleomycin: in vitro stability and toxicity on human cutaneous keratinocyte cell lines’. Int J Pharm 2005;300(1-2):4-12 |
| S Chopra, F Jabber, S Pereira. ‘Anticonvulsant hypersensitivity disorder’. Journal of Psychiatric Intensive Care. Vol 1. 2:117-120. 2005 | |
| ‘Dermatological problems’ F Vega-Lopez and S. Chopra. Manson’s 21stth Edition ‘Textbook of Infectious Disease’ 2003 | |
| S. Chopra and A.C Chu. “Treatment of Cancer” Eds Pat Price and Karol Sikora. 4th Edition. Arnold 2002. Chapter 38 ‘Non-Melanoma Skin Cancer’. PP 799-830 | |
| Clin Exp Dermatol. 2001 Sep; 26(6):510-2 ‘Erythema gyratum repens and acquired ichthyosis associated with transitional cell carcinoma of the kidney.’ Ameen M, Chopra S, Darvay A, Acland K, Chu AC. |
|
| S. Chopra, P.Human and A.C Chu. ‘Antihistamines in atopic dermatitis’. CME Bulletin Dermatology.1999 (2); 1, 16-19. | |
| Pauline M Dowd, P. Goldsmith, S. Chopra, H.A Bull and JC Foreman. ‘Cutaneous responses to endothelin-1 and histamine in patients with vibration white finger’. J Invest Dermatol. 1999 Feb; 110(2): 127-31 | |
| S. Chopra, S.Munn and A.C Chu. ‘B-cell lymphoma presenting as Langerhans cell histiocytosis. BAD proceedings’ Br J of Dermatol. 1999, 141 supplement 55. 128 | |
| S. Chopra and F Vega-Lopez. “The Granulomatous disorders” Eds: D.Geraint James and Alimuddin Zumla. Cambridge University Press 1999. Chapter 33-Skin Granulomas in Clinical Practice. PP 485-525 | |
| Bull HA, Leslie TA, Chopra S, Dowd PM. ‘Expression of nerve growth factor receptors in cutaneous inflammation’. Br J Dermatol 1998;139(5):776-83 | |
| S. Chopra, N.J. Levell, G. Cowley and J.J.H. Gilkes. ‘Systemic Corticosteroids in the phenytoin hypersensitivity syndrome’. Br J of Dermatol 1996; 134: 1109-1112. | |
| S. Chopra, M.M.L Martins and PM. Dowd. ‘Increased expression of nerve growth factor, p75 nerve growth factor receptor and GAP 43 in systemic sclerosis’: BSID proceedings. Br J of Dermatol 1996; 134: 592. | |
| S. Chopra, M.M.L Martins and P. M. Dowd. ‘Comparison of the expression of nerve growth factor, p75 nerve growth factor receptor, trk A and GAP 43 in systemic sclerosis and vibration white finger’ SID proceedings J Invest Dermatol 1996, 106: 821. | |
| N.J Levell, A.P. Bewley, S. Chopra, D. Churchill, P. French, R. Miller and J.J.H. Gilkes. ‘Bacillary angiomatosis with cutaneous and oral lesions in an HIV-infected patient from the U.K.’ Br J of Dermatol 1995; 132: 113-115. | |
| S. Chopra, H. A. Bull and Pauline M. Dowd. ‘Nerve Growth Factor and its receptors in relation to GAP 43 and cutaneous nerve fibre depletion in Vibration White Finger’. In preparation. S. Chopra, H.A Bull & Pauline M. Dowd. Nerve Growth Factor & its receptor p75 & GAP 43 are upregulated in the Raynaud’s phenomenon of Systemic sclerosis but not in Primary Raynaud’s phenomenon. In preparation. |
|
| Postgraduate Book Chapter: | ‘Dermatological problems’ S Chopra, M Knight, and F Vega Lopez Manson’s 22nd Edition ‘Textbook of Infectious Disease’ 2009 |
| ‘Dermatological problems’ F Vega-Lopez and S. Chopra. Manson’s 21stth Edition ‘Textbook of Infectious Disease’ 2003 | |
| S. Chopra and A.C Chu. “Treatment of Cancer” Eds Pat Price and Karol Sikora. 4th Edition. Arnold 2002. Chapter 38 ‘Non-Melanoma Skin Cancer’. PP 799-830 | |
| S. Chopra and F Vega-Lopez. “The Granulomatous disorders” Eds: D.Geraint James and Alimuddin Zumla. Cambridge University Press 1999. Chapter 33-Skin Granulomas in Clinical Practice. PP 485-525 | |
| Presentations at Scientific Meetings: International: |
P. Timpanides, S. Chopra, P.M Dowd, H.E Kemp and J.G Gawkroger. Transplacental transfer of anti tyrosinase IgG antibodies causing vitiligo in a newborn baby. American Academy of Dermatology. San-Francisco-March 2000 |
| A.C. Chu, S. Chopra and M Amheen. Calipitriol in vitiligo an open study. European Academy of Dermatology and Veneorology- Amsterdam, 29 September-4 October 1999 | |
| S.Datta, S. Chopra and PM Dowd. Vascular hyporeactivity in acrocyanosis and perniosis. American Academy of Dermatology Annual Conference May 23-28 1999-Chicago | |
| H. A. Bull, S. Chopra, PM. Dowd. Nerve Growth Factor and its receptors and GAP 43 in cutaneous inflammation and vasospasm. 55th Annual Meeting of American Academy of Dermatology, 21-26th March 1997 - San Francisco. | |
| S. Chopra, H. A. Bull and Pauline M. Dowd. Diltiazem therapy partially reverses the cutaneous nerve fibre depletion of Vibration White Finger. 25th Anniversary Meeting European Society for Dermatological Research, 28th September-1st October 1996 – Amsterdam | |
| S. Chopra, M.M.L. Martins and P.M. Dowd. Comparison of the expression of nerve growth factor, p75 nerve growth factor receptor, trk A and GAP 43 in systemic sclerosis and vibration white finger. Society of Investigative Dermatology, 1-5th May 1996 - Washington DC. | |
| H. A. Bull, S. Chopra and Pauline M Dowd. Neuropeptides, Vasospasm and cutaneous inflammation. 45th Annual Symposium on the biology of skin, 20-24th May 1996 - Snowmass, Colorado |
|
| Anthony ET, Vaiude PN, Syed M, Chopra S, Rattan B, Navsaria H The use of skin explants and primary cells in testing nano liposomal topical keloid treatments; Tissue Engineering, Wurzburg, Germany May 2006 | |
| Anthony ET, Vaiude PN, Chopra S, Syed M, Rattan B, Leigh I, Navsaria H. Treatment of keloids with liposomes.Scars 2006, Montpellier, France 29 March 2006 | |
| National: | Anthony ET, Vaiude PN, Syed M, Chopra S, Navsaria H; Nano-liposomal Bleomycin: The future for BCC treatment; Brit Assoc of Plastic Surgery summer meeting, Sheffield; 12 July 2006– Poster |
| Anthony ET, Chopra S, Moir GC, Navsaria HN. Emerging Nano-liposomal technology for BCC treatment. West Midlands National Plastics and Burns Surgery Meeting; October 2005 | |
| S. Chopra, S. Munn and A.C. Chu. B-cell lymphoma presenting as Langerhans cell histiocytosis. British Association of Dermatology 79th Annual Meeting, 29 June – 3 July 1999- Edinburgh | |
| S. Chopra, V. Exarchou and A.C. Chu. Digital videomicroscopy in the follow up of pigmented skin lesions. British Association of Dermatology 79th Annual Meeting, 29 June – 3 July 1999- Edinburgh | |
| S. Chopra, M.M.L Martins and Pauline M. Dowd. Increased expression of nerve growth factor, p75 nerve growth receptor and GAP 43 in systemic sclerosis. British Society of Investigative Dermatology, 28 -29th March 1996 – Glasgow | |
| University Poster Presentation: | Anthony ET, Lau K, Trigiante G, Chopra S,Moir GC, Navsaria HN. Bleomycin in an Ultra Deformable Liposome. William Harvey Day, Great Hall, St Bartholomew’s Hospital, Queen Mary, University of London; October 2005 |
| Presentations at Royal Society of Medicine Section of Dermatology: | S. Chopra and A.C Chu. CD30+ lymphoma occurring in a patient with a diagnosis of psoriasis. November 1999 |
| S. Chopra and R. Russell Jones. Cutaneous vasculitis and hepatitis C infection. February 1999 | |
| S. Chopra and N.J Lowe Transplacental transfer of antityrosinase IgG antibody causing vitiligo in a newborn baby. March 1998 | |
| S. Chopra and R.Groves. A case of hereditary anetoderma. March 1998 | |
| S. Chopra and R.Y Yu. Vesicular eruption in a case of Churg Strauss vasculitis CPC. January 1998 | |
| S. Chopra and P.M Dowd. Primary erthromelalgia. 17th April 1997 | |
| S. Chopra and R.Y Yu. Spontaneous graft versus host disease 17th April 1997 | |
| S. Chopra and J.J.H. Gilkes. Phenytoin hypersensitivity syndrome. 15th June 1995 | |
| Presentations at Grand Rounds: | B-Cell Lymphoma presenting as Langerhans histiocytosis. Hammersmith Hospital, July 1999 |
| Bullous pemphigoid associated with malignancy. Hammersmith Hospital, April 1999 | |
| Churg Strauss syndrome presenting as blindness. Hammersmith Hospital, February 1999 | |
| Phenytoin hypersensitivity syndrome. Hammersmith Hospital, July 1998 Primary erythromelalgia. UCL Hospitals, February 1998 |
|
| Epidermodysplasia verruciformis. UCL Hospitals, November 1997 | |
| St John’s Registrar meetings: | Presented on 2 occasions - October 1998 and June 1999 |
| Courses Organised: | UCL Hospitals NHS Trust – Annual Teaching Course for general practitioners – lectured on two occasions |
| Hammersmith Hospitals NHS Trust – Annual Practice Nurses Course – lectured on two occasions. | |
| Courses Attended: | Hammersmith Hospitals Skin Histopathology Course – May 1999 |
|
Novartis Management Course – February 1998 |
|
Skin Biology Course – Cambridge 1996 |
| Medical School Activities: | Elected the first University College and Middlesex School of Medicine Students Union president 1986-87 |

